SUBSCRIPTION AGREEMENT ----------------------Subscription Agreement • September 28th, 2009 • Enzyme Bio Systems
Contract Type FiledSeptember 28th, 2009 CompanyThe undersigned investor ("Investor") in this Subscription Agreement ("Agreement") hereby acknowledges receipt of the prospectus ("Prospectus"), dated __________________, 2009 of EnzymeBioSystems, a Nevada corporation, and subscribes for the following number of shares upon the terms and conditions set forth in the Prospectus. The Investor agrees that this Agreement is subject to availability and acceptance by EnzymeBioSystems.
Class C WarrantClass C Warrant • December 14th, 2017 • EnzymeBioSystems • Pharmaceutical preparations • Nevada
Contract Type FiledDecember 14th, 2017 Company Industry JurisdictionTHIS WARRANT AND THE SHARES ISSUABLE HEREUNDER HAVE NOT BEEN REGISTER THE SECURITIES ACT OF 1933, AS AMENDED, AND MAY NOT BE SOLD, PLEDGED, OR OTHERWISE TRANSFERRED WITHOUT AN EFFECTIVE REGISTRATION THEREOF UNDER SUCH ACT OR PURSUANT TO RULE 144 OR AN OPINION OF COUNSEL REASONABLY SATISFACTORY TO THE CORPORATION AND ITS COUNSEL, THAT SUCH REGISTRATION IS NOT REQUIRED.
AGREEMENT BETWEEN ENZYMEBIOSYSTEMS, INC. and NORTHEASTERN OHIO UNIVERSITIES COLLEGE OF MEDICINEResearch and Development • October 13th, 2010 • EnzymeBioSystems • Pharmaceutical preparations • Ohio
Contract Type FiledOctober 13th, 2010 Company Industry Jurisdiction
Class B WarrantsClass B Warrant Agreement • December 14th, 2017 • EnzymeBioSystems • Pharmaceutical preparations • Nevada
Contract Type FiledDecember 14th, 2017 Company Industry JurisdictionTHIS WARRANT AND THE SHARES ISSUABLE HEREUNDER HAVE NOT BEEN REGISTER THE SECURITIES ACT OF 1933, AS AMENDED, AND MAY NOT BE SOLD, PLEDGED, OR OTHERWISE TRANSFERRED WITHOUT AN EFFECTIVE REGISTRATION THEREOF UNDER SUCH ACT OR PURSUANT TO RULE 144 OR AN OPINION OF COUNSEL REASONABLY SATISFACTORY TO THE CORPORATION AND ITS COUNSEL, THAT SUCH REGISTRATION IS NOT REQUIRED.
Securities Purchase AgreementSecurities Purchase Agreement • December 14th, 2017 • EnzymeBioSystems • Pharmaceutical preparations • Nevada
Contract Type FiledDecember 14th, 2017 Company Industry JurisdictionThe undersigned (the “Investor”) hereby confirms its agreement with EnzymeBioSystems, a Nevada corporation (the “Company”), as follows:
EXCLUSIVE TECHNOLOGY LICENSE AND PATENTS AGREEMENTExclusive Technology License and Patents Agreement • February 1st, 2011 • EnzymeBioSystems • Pharmaceutical preparations
Contract Type FiledFebruary 1st, 2011 Company Industry
BUSINESS PURCHASE AgreementBusiness Purchase Agreement • February 27th, 2017 • EnzymeBioSystems • Pharmaceutical preparations • Nevada
Contract Type FiledFebruary 27th, 2017 Company Industry JurisdictionThis Business Purchase Agreement (the “Agreement”) is made and entered into this 12th day of January 2016, by and among EnzymeBioSystems ("ENZB"), a Nevada corporation, Shareholder Acquisition Corp., ("Subsidiary"), a Nevada corporation and subsidiary of ENZB and EZJR, Inc., ("EZJR") a Nevada corporation, soon to be call Her Imports (collectively the "Parties.").
Class A WarrantClass a Warrant • December 14th, 2017 • EnzymeBioSystems • Pharmaceutical preparations • Nevada
Contract Type FiledDecember 14th, 2017 Company Industry JurisdictionTHIS WARRANT AND THE SHARES ISSUABLE HEREUNDER HAVE NOT BEEN REGISTER THE SECURITIES ACT OF 1933, AS AMENDED, AND MAY NOT BE SOLD, PLEDGED, OR OTHERWISE TRANSFERRED WITHOUT AN EFFECTIVE REGISTRATION THEREOF UNDER SUCH ACT OR PURSUANT TO RULE 144 OR AN OPINION OF COUNSEL REASONABLY SATISFACTORY TO THE CORPORATION AND ITS COUNSEL, THAT SUCH REGISTRATION IS NOT REQUIRED.
Purchase AgreementPurchase Agreement • May 6th, 2014 • EnzymeBioSystems • Pharmaceutical preparations • Nevada
Contract Type FiledMay 6th, 2014 Company Industry JurisdictionTHIS PURCHASE AGREEMENT is entered into as of the 2nd day of May, 2014, by and between EnzymeBioSystems (“ENZB”), a Nevada Corporation, and Berkeley Clinic, LP (“Berkeley”), an Arizona Limited Liability Company (collectively referred to herein as the "Parties").